May 23, 2018 / 7:56 AM / a month ago

BRIEF-Amoy Diagnostics To Invest In U.S. Firm Universal Sequencing Technology

* SAYS IT PLANS TO INVEST $8 MILLION IN U.S. FIRM UNIVERSAL SEQUENCING TECHNOLOGY CORP’S PREFERRED SHARES

* SAYS IT WILL OWN 18.986 PERCENT OF TOTAL ISSUED SHARES IN UNIVERSAL SEQUENCING TECHNOLOGY AFTER THE TRANSACTION Source text in Chinese: bit.ly/2s26lzZ Further company coverage: (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below